Terms | Characteristics | Case | Control | p value* |
---|---|---|---|---|
All | All | 44 | 51 | |
Month Age | 42.28 ± 4.68 | 51.35 ± 2.02 | 0.081 | |
CpG1(%) | 41.46 ± 2.63 | 56.84 ± 1.48 | 2.93E-06 | |
CpG2(%) | 39.49 ± 2.32 | 51.64 ± 1.35 | 2.35E-05 | |
CpG3(%) | 37.36 ± 2.39 | 50.68 ± 1.30 | 6.46E-06 | |
CpG4(%) | 44.45 ± 2.91 | 61.45 ± 1.56 | 2.47E-06 | |
CpG5(%) | 31.58 ± 1.93 | 42.24 ± 1.22 | 1.26E-05 | |
Means methylation(%) | 38.87 ± 2.43 | 52.57 ± 1.35 | 5.42E-06 | |
Age | ≤ 36 months | 24 | 10 | |
CpG1(%) | 49.98 ± 3.62 | 65.42 ± 1.93 | 0.00069 | |
CpG2(%) | 46.86 ± 3.24 | 59.85 ± 1.55 | 0.00107 | |
CpG3(%) | 45.42 ± 3.29 | 58.358 ± 1.80 | 0.00163 | |
CpG4(%) | 54.31 ± 3.87 | 70.749 ± 2.646 | 0.00137 | |
CpG5(%) | 37.62 ± 2.71 | 49.89 ± 1.938 | 0.00087 | |
Means methylation(%) | 46.84 ± 3.33 | 60.85 ± 1.88 | 0.00091 | |
> 36 months | 20 | 41 | ||
CpG1(%) | 31.24 ± 2.32 | 54.75 ± 1.62 | 7.98E-15 | |
CpG2(%) | 30.65 ± 1.99 | 49.63 ± 1.48 | 8.98E-13 | |
CpG3(%) | 27.68 ± 1.93 | 48.81 ± 1.408 | 1.13E-15 | |
CpG4(%) | 32.62 ± 2.71 | 59.186 ± 1.653 | 1.62E-16 | |
CpG5(%) | 24.32 ± 1.65 | 40.373 ± 1.28 | 2.02E-12 | |
Means methylation(%) | 29.30 ± 2.09 | 50.55 ± 1.45 | 5.49E-15 | |
Gender | Male | 31 | 46 | |
CpG1(%) | 43.98 ± 3.49 | 58.26 ± 1.38 | 4.87E-04 | |
CpG2(%) | 41.62 ± 3.09 | 52.77 ± 1.33 | 0.002 | |
CpG3(%) | 39.89 ± 3.14 | 51.85 ± 1.25 | 0.001 | |
CpG4(%) | 47.55 ± 3.80 | 62.75 ± 1.54 | 6.40E-04 | |
CpG5(%) | 33.21 ± 2.57 | 43.18 ± 1.20 | 0.001 | |
Means methylation(%) | 41.25 ± 3.21 | 53.76 ± 1.30 | 8.38E-04 | |
Female | 13 | 5 | ||
CpG1(%) | 35.47 ± 2.66 | 43.85 ± 5.77 | 0.15 | |
CpG2(%) | 34.43 ± 2.31 | 41.20 ± 4.28 | 0.156 | |
CpG3(%) | 31.32 ± 2.48 | 39.92 ± 4.57 | 0.098 | |
CpG4(%) | 37.05 ± 3.14 | 49.49 ± 4.94 | 0.052 | |
CpG5(%) | 27.67 ± 1.95 | 33.54 ± 4.37 | 0.172 | |
Means methylation(%) | 33.19 ± 2.49 | 41.60 ± 4.71 | 0.108 |